Group One Trading’s Cytosorbents Corp CTSO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-4,263
Closed -$12.2K 7738
2023
Q2
$15.3K Sell
4,263
-4,500
-51% -$14.2K ﹤0.01% 6155
2023
Q1
$29.5K Buy
8,763
+8,745
+48,583% +$26.2K ﹤0.01% 5252
2022
Q4
$28 Sell
18
-1,636
-99% -$2.43K ﹤0.01% 7106
2022
Q3
$2K Hold
1,654
﹤0.01% 7125
2022
Q2
$4K Buy
+1,654
New +$3.8K ﹤0.01% 7180
2021
Q4
Sell
-1,654
Closed -$9.28K 8300
2021
Q3
$13K Buy
+1,654
New +$13.4K ﹤0.01% 7376
2020
Q2
Sell
-6,648
Closed -$61.1K 5834
2020
Q1
$51K Buy
+6,648
New +$33.6K ﹤0.01% 3701
2019
Q4
Sell
-392
Closed -$2K 5178
2019
Q3
$2K Buy
392
+300
+326% +$1.75K ﹤0.01% 4906
2019
Q2
$1K Hold
92
﹤0.01% 4808
2019
Q1
$1K Sell
92
-4,572
-98% -$35.6K ﹤0.01% 4654
2018
Q4
$38K Sell
4,664
-327
-7% -$3.25K ﹤0.01% 3685
2018
Q3
$64K Sell
4,991
-5,230
-51% -$65.6K ﹤0.01% 3825
2018
Q2
$117K Buy
+10,221
New +$96.8K ﹤0.01% 3443
2017
Q4
Sell
-254
Closed -$1.62K 4893
2017
Q3
$2K Sell
254
-4,200
-94% -$21.4K ﹤0.01% 4635
2017
Q2
$19K Sell
4,454
-1,900
-30% -$8.33K ﹤0.01% 3965
2017
Q1
$29K Buy
6,354
+5,000
+369% +$27.9K ﹤0.01% 3703
2016
Q4
$7K Buy
1,354
+100
+8% +$547 ﹤0.01% 4023
2016
Q3
$8K Buy
+1,254
New +$6.52K ﹤0.01% 4105

Other funds holding CTSO

Group One Trading's CTSO Position: Q3 2023 in Review

Group One Trading sold out of Cytosorbents Corp (CTSO) in Q3 2023, closing a stake of 4,263 shares — an estimated $12.2K sold.

Group One Trading first reported a position in CTSO in Q3 2016 and held it in 18 quarters. The position peaked at $117K in Q2 2018. 53 funds tracked by Wall St. Rank hold CTSO as of Q3 2023.

  • Group One Trading reported no remaining Cytosorbents Corp position as of Q3 2023 after selling out during the quarter.
  • Group One Trading sold 4,263 Cytosorbents Corp shares in Q3 2023, an estimated $12.2K.
  • Group One Trading first reported a position in Cytosorbents Corp in Q3 2016 and held it in 18 quarters.
  • Group One Trading's Cytosorbents Corp position peaked at $117K in Q2 2018.
  • 53 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q3 2023.

Based on Group One Trading's 13F filing for Q3 2023, filed 9 Nov 2023.